Interim guidance for influenza treatment with limited oseltamivir; FDA panel take vote on omecamtiv mecarbil; Tecentriq gains new indication; Potential combo COVID-19 and influenza vaccine; Detect COVID-19 tests recalled.
Please login or register first to view this content.